Search company, investor...

UniCel Lab

Founded Year



Grant | Alive

About UniCel Lab

UniCel Lab develops crystallization medicines. The company's medicines offer crystal form screening, design, and control of raw pharmaceutical materials, crystallization consultation for drug substances, and different forms of analysis, enabling customers to get various crystal forms such as polymorphs, amorphous, and salt form. It was founded in 2018 and is based in Uiwang-si, South Korea.

Headquarters Location

The Live Bizwon 1, 25, Obongsandan 3-ro 11F


South Korea

Missing: UniCel Lab's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: UniCel Lab's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

UniCel Lab Frequently Asked Questions (FAQ)

  • When was UniCel Lab founded?

    UniCel Lab was founded in 2018.

  • Where is UniCel Lab's headquarters?

    UniCel Lab's headquarters is located at The Live Bizwon 1, 25, Obongsandan 3-ro, Uiwang-si.

  • What is UniCel Lab's latest funding round?

    UniCel Lab's latest funding round is Grant.

  • Who are the investors of UniCel Lab?

    Investors of UniCel Lab include TIPS Program, Synergy IB Investment, Yozma Group Korea and Yozma Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.